Epstein Secrets

esident says in this tweet, it's just wrong, it's regrettable, it's counterproductive." CNN White House correspondent Kaitlin Collins said on CNN's Inside PoliticsVi (11/15, 766K), "This could be the closest we get to a concession from President Trump. This is what people around him have been giving us a heads u

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

esident says in this tweet, it's just wrong, it's regrettable, it's counterproductive." CNN White House correspondent Kaitlin Collins said on CNN's Inside PoliticsVi (11/15, 766K), "This could be the closest we get to a concession from President Trump. This is what people around him have been giving us a heads u

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

esident says in this tweet, it's just wrong, it's regrettable, it's counterproductive." CNN White House correspondent Kaitlin Collins said on CNN's Inside PoliticsVi (11/15, 766K), "This could be the closest we get to a concession from President Trump. This is what people around him have been giving us a heads u

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying